Basic Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Oct 15, 2020; 12(10): 1104-1118
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1104
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Immunohistochemical staining for KIF23 protein in gastric cancer. A: Negative; B: Low expression; C: Medium expression; D: High expression.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 KIF23 mRNA expression in tumors according to Oncomine database. A statistically significant dataset of high (red) or low (blue) KIF23 gene expression (cancer vs normal).
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Expression of KIF23 in gastric cancer in Oncomine database. A-E: The results of the five studies involved. The darker the red, the higher the expression of KIF23 in the chip.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Prognostic effect of KIF23 expression in subgroups with different clinicopathological characteristics. A: Kaplan–Meier analysis of the overall survival (OS) rate between the low- and high-KIF23 expression groups. Median OS in the low- and high-KIF23 expression groups was 41 and 26 mo, respectively; B–I: Kaplan–Meier analysis of OS rate between the low- and high-KIF23 expression groups in GC patients with different T, N, and tumor–node–metastasis stages, and differentiation types.